Αρχειοθήκη ιστολογίου

Δευτέρα 2 Οκτωβρίου 2017

First-Ever CAR T-cell Therapy Approved in U.S. [News in Brief]

The first chimeric antigen receptor T-cell therapy, tisagenlecleucel, received FDA approval for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia who haven't responded to standard therapy or who have relapsed at least twice.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2xc6NLA

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου